Suppr超能文献

关于暴露边际方法的使用与解读的声明

Statement on the use and interpretation of the margin of exposure approach.

作者信息

Bennekou Suzanne Hougaard, Allende Ana, Bearth Angela, Casacuberta Josep, Castle Laurence, Coja Tamara, Crépet Amélie, Halldorsson Thorhallur, Hoogenboom Laurentius Ron, Knutsen Helle, Lambré Claude, Nielsen Søren, Turck Dominique, Civera Antonio Vicent, Villa Roberto, Jokelainen Pikka, Zorn Holger, Benford Diane, Fitzgerald Rex, Meek Bette, Mortensen Alicja, Sand Salomon, Testai Emanuela, Manini Paola, Paini Alicia, Schrenk Dieter

出版信息

EFSA J. 2025 Aug 8;23(8):e9606. doi: 10.2903/j.efsa.2025.9606. eCollection 2025 Aug.

Abstract

The margin of exposure (MOE) is a risk assessment tool used to evaluate the safety of substances in food and feed. Adopted by the European Food Safety Authority (EFSA) in 2005, the MOE is calculated as the ratio between a Reference Point (RP) and the estimated exposure. While some regulatory bodies use 'margin of safety' (MOS) interchangeably with MOE, others define it differently, leading to inconsistencies in interpretation. To address this, EFSA has standardised its terminology, establishing MOE as a primary metric for safety assessments across human and animal health evaluations. In addition, the meaning and interpretation of terms used to qualify a 'concern' is elaborated. The EFSA definitions will come into force from when this statement is published. By refining these definitions and ensuring consistent terminology across sectors, EFSA aims to improve clarity and transparency in its risk assessments, facilitating effective communication.

摘要

暴露边际(MOE)是一种用于评估食品和饲料中物质安全性的风险评估工具。欧洲食品安全局(EFSA)于2005年采用了MOE,它被计算为参考点(RP)与估计暴露量之间的比率。虽然一些监管机构将“安全边际”(MOS)与MOE互换使用,但其他机构对其定义不同,导致解释上的不一致。为了解决这个问题,EFSA对其术语进行了标准化,将MOE确立为人类和动物健康评估中安全评估的主要指标。此外,还阐述了用于限定“关注”的术语的含义和解释。EFSA的定义将自本声明发布之日起生效。通过完善这些定义并确保各部门术语的一致性,EFSA旨在提高其风险评估的清晰度和透明度,促进有效沟通。

相似文献

1
Statement on the use and interpretation of the margin of exposure approach.关于暴露边际方法的使用与解读的声明
EFSA J. 2025 Aug 8;23(8):e9606. doi: 10.2903/j.efsa.2025.9606. eCollection 2025 Aug.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
9
Pharmacological treatment of children with gastro-oesophageal reflux.胃食管反流患儿的药物治疗
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD008550. doi: 10.1002/14651858.CD008550.pub2.

本文引用的文献

5
Guidance on the use of the benchmark dose approach in risk assessment.风险评估中基准剂量法的使用指南。
EFSA J. 2022 Oct 25;20(10):e07584. doi: 10.2903/j.efsa.2022.7584. eCollection 2022 Oct.
7
Scientific Guidance for the submission of dossiers on Food Enzymes.食品酶制剂资料提交的科学指南。
EFSA J. 2021 Oct 21;19(10):e06851. doi: 10.2903/j.efsa.2021.6851. eCollection 2021 Oct.
10
Guidance on Uncertainty Analysis in Scientific Assessments.科学评估中的不确定性分析指南。
EFSA J. 2018 Jan 24;16(1):e05123. doi: 10.2903/j.efsa.2018.5123. eCollection 2018 Jan.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验